Xellia starts sterile injectable production at once vilified U.S. plant 

After nearly five years and significant investment, commercial production is again underway at a plant that was once the poster-child of pharma production quality failures. After a January inspection, the FDA has given its nod of approval for Xellia Pharmaceuticals to start manufacturing at the sterile injectables plant in the Cleveland, Ohio suburb of Bedford. 

Leave a Reply

Your email address will not be published. Required fields are marked *